- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02725203
Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients
Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients With a Cardiovascular Risk: a Clustered-randomized Controlled Trial in Primary Care
A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 279 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period. Primary outcome is the level of physical activity measured with an accelerometer. Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.
Nurses will be trained in delivering the intervention by a one-day training and coaching sessions supervised. A process evaluation will be conducted.
Study Overview
Detailed Description
Self-management interventions are considered effective in chronic disease patients, but trials have shown inconsistent results and it is unknown which patients benefit most. Adequate self-management requires behaviour change in patients and in healthcare providers to equip them in supporting patients in changing their behaviour. To unravel effectiveness of self-management, a nurse-led intervention was developed targeting at one self-management behaviour, namely physical activity, in primary care patients at risk for cardiovascular disease: the Activate intervention. This study aims to evaluate the effectiveness of the Activate intervention, to identify which patient-related characteristics modify change in physical activity levels in patients at risk for CVD in primary care, and to conduct a process evaluation.
A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 300 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period in which 17 behaviour change techniques (BCTs) are integrated. Primary outcome is the level of physical activity measured with an accelerometer . Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.
Subsequently, the BCW was applied to analyse what behavior change is needed in nurses to deliver the Activate intervention adequately. This resulted in a one-day training and coaching sessions supervised by a health psychologist and included 21 BCT.
A process evaluation will be conducted to evaluate the training of nurses, fidelity, dose and reach of the Activate intervention, identify barriers and facilitators for implementation and to assess participants' satisfaction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Utrecht, Netherlands, 3531 HX
- GP Lombok
-
-
Brabant
-
Asten, Brabant, Netherlands, 5721CM
- GP Lienderweg
-
Drunen, Brabant, Netherlands, 5151 HA
- GP Timmerman
-
s Hertogenbosch, Brabant, Netherlands, 5235KG
- GP Emmers
-
-
Gelderland
-
Ede, Gelderland, Netherlands, 6713 NS
- GP Klaar and Vincent
-
Hoevelaken, Gelderland, Netherlands, 3871EE
- GP Parklaan
-
-
Gerlderland
-
Buren, Gerlderland, Netherlands, 4116CW
- GP Buren
-
-
Noord Holland
-
Hilversum, Noord Holland, Netherlands, 1223DT
- GP Seinhorst
-
-
Noord-Holland
-
Amstelveen, Noord-Holland, Netherlands, 1186PJ
- GP Tjin a Ton and Parlevliet
-
Bennebroek, Noord-Holland, Netherlands, 2121BB
- GP De Kennemerpoort
-
Heerhugowaard, Noord-Holland, Netherlands, 1701 ER
- GP Odijk-Visser
-
Heerhugowaard, Noord-Holland, Netherlands, 1701ER
- GP Munster
-
Hilversum, Noord-Holland, Netherlands, 1215EK
- GP Eedenburgh
-
Koedijk, Noord-Holland, Netherlands, 1831EK
- GP Koedijk
-
Nieuw Vennep, Noord-Holland, Netherlands, 2152CA
- GP De Hollenhorst
-
Wassenaar, Noord-Holland, Netherlands, 2241KE
- GP Spelt
-
-
Overijssel
-
Colmschate, Overijssel, Netherlands, 7429BG
- GP Jonker
-
Kampen, Overijssel, Netherlands, 8265 DN
- GP Amarant
-
Markelo, Overijssel, Netherlands, 7475AG
- GP Rosing and Bruins Slot
-
Zwolle, Overijssel, Netherlands, 8042AD
- GP Blanker, Thiele, Brand
-
-
Utrecht
-
Bilthoven, Utrecht, Netherlands, 3723RC
- GP Provostlaan
-
Bunnik, Utrecht, Netherlands, 3981EV
- GP van Steenis
-
De BIlt, Utrecht, Netherlands, 3732BG
- GP De Bilt
-
Leusden, Utrecht, Netherlands, 3831JR
- GP Tolgaarde
-
Odijk, Utrecht, Netherlands, 3984MA
- GP Odijk
-
Woudenberg, Utrecht, Netherlands, 3931 KJ
- GP De Schans
-
-
Zuid-Holland
-
Alphen aan den Rijn, Zuid-Holland, Netherlands, 2408 LA
- GP Sparreboom
-
Boskoop, Zuid-Holland, Netherlands, 2771 EN
- GP Wiechen
-
Schoonrewoerd, Zuid-Holland, Netherlands, 4145NV
- GP De Wiel
-
The Hague, Zuid-Holland, Netherlands, 2525CE
- GP Mozaiek
-
The Hague, Zuid-Holland, Netherlands, 2593WB
- GP Loudon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Aged 40-75
AND at least one of the following criteria:
- have a high blood pressure (≥ 140 mmHg) or are already treated for high blood pressure
- have a high total cholesterol (≥ 6.5 mmol/l) or already treated for high cholesterol
- have diabetes mellitus type 2 (DM2)
- have a positive family history of CVD AND Do not meet the Dutch Norm for Healthy Exercise according to the Short QUestionnaire to Asses Health (SQUASH).
Exclusion Criteria:
- unable to give informed consent (eg. due to cognitive impairment),
- unable to speak, write and read Dutch,
- have contra-indications to increase their physical activity level (eg. unstable angina pectoris, unstable heart failure, acute illness)
- have a terminal illness or have severe psychiatric illness or chronic disorder(s) that seriously influence the ability to improve their psychical activity level.
- patients should not have participated in a program to increase their level of physical activity in the past 2 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention: Activate intervention
Participants in the intervention arm will visit their primary care nurse four times in a three-month period for structured and comprehensive support in achieving an improved level of physical activity.
|
The Activate intervention consists of four nurse-led consultations in a thee-month period.
In the consultations patients receive structured and comprehensive support in achieving an improved level of physical activity.
The Behavior Change Wheel was used to develop the Activate intervention, and led to a selection of 17 behavior change techniques, which are integrated in the Activate intervention
|
|
No Intervention: Control
Patients in the control arm will receive care as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
level of physical activity measured with the Personal Activity Monitor (PAM AM300)
Time Frame: baseline - 6 months of follow up
|
The amount of minutes of physical activity in the moderate (3-6 METabolic equivalent (METS)) and vigorous categories (≥6 METS) at 6 months of follow up will be considered as primary outcome measure.
Patients will be asked to wear the accelerometer during 7 consecutive days for 12 hours a day at baseline (T0), 3 months of follow up (T1) and at 6 months of follow up (T2).
|
baseline - 6 months of follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)
Time Frame: baseline -3 months and 6 months of follow up
|
Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)
|
baseline -3 months and 6 months of follow up
|
|
Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS)
Time Frame: baseline - 3 months and 6 months of follow up
|
Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS), baseline, T0, T1, T2
|
baseline - 3 months and 6 months of follow up
|
|
Patient activation using the Patient Activation Measure (PAM-13)
Time Frame: baseline -3 months and 6 months of follow up
|
Patient activation using the Patient Activation Measure (PAM-13)
|
baseline -3 months and 6 months of follow up
|
|
Health status using the EQ-5D
Time Frame: baseline - 6 months of follow up
|
Health status using the EQ-5D
|
baseline - 6 months of follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Potential effect modifier: age
Time Frame: baseline
|
does age modify change in physical activity level
|
baseline
|
|
Potential effect modifier: depression using the Hospital Anxiety and Depression Scale (HADS)
Time Frame: baseline
|
does depression modify change in physical activity level
|
baseline
|
|
Potential effect modifier: Body Mass Index (BMI)
Time Frame: baseline
|
does BMI modify change in physical activity level
|
baseline
|
|
Potential effect modifier: level of education
Time Frame: baseline
|
does education level modify change in physical activity
|
baseline
|
|
Potential effect modifier: social support using Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: baseline,
|
does social support modify change in level of physical activity
|
baseline,
|
|
Potential effect modifier: patient-provider relationship using the Communication Assessment Tool (CAT)
Time Frame: baseline, 3 months and 6 months of follow up
|
does the patient-provider relationship modify change in level of physical activity
|
baseline, 3 months and 6 months of follow up
|
|
Potential effect modifier: baseline amount of minutes of moderate to vigorous level of physical activity using the PAM AM300
Time Frame: baseline
|
does baseline amount of minutes of moderate to vigorous level of physical activity modify change in level of physical activity
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Marieke J. Schuurmans, PhD, UMC Utrecht
- Principal Investigator: Heleen Westland, MSc, UMC Utrecht
- Principal Investigator: Irene D Bos-Touwen, MSc, UMC Utrecht
- Study Chair: Jaap CA Trappenburg, PhD, UMC Utrecht
- Study Chair: Carin D Schröder, PhD, UMC Utrecht
Publications and helpful links
General Publications
- Westland H, Trappenburg JCA, Schuurmans MJ, Zonneveld MH, Schroder CD. Fidelity of primary care nurses' delivery of a behavioural change intervention enhancing physical activity in patients at risk of cardiovascular disease: an observational study. BMJ Open. 2021 Mar 23;11(3):e046551. doi: 10.1136/bmjopen-2020-046551.
- Westland H, Schuurmans MJ, Bos-Touwen ID, de Bruin-van Leersum MA, Monninkhof EM, Schroder CD, de Vette DA, Trappenburg JC. Effectiveness of the nurse-led Activate intervention in patients at risk of cardiovascular disease in primary care: a cluster-randomised controlled trial. Eur J Cardiovasc Nurs. 2020 Dec;19(8):721-731. doi: 10.1177/1474515120919547. Epub 2020 May 6.
- Westland H, Sluiter J, Te Dorsthorst S, Schroder CD, Trappenburg JCA, Vervoort SCJM, Schuurmans MJ. Patients' experiences with a behaviour change intervention to enhance physical activity in primary care: A mixed methods study. PLoS One. 2019 Feb 12;14(2):e0212169. doi: 10.1371/journal.pone.0212169. eCollection 2019.
- Westland H, Koop Y, Schroder CD, Schuurmans MJ, Slabbers P, Trappenburg JCA, Vervoort SCJM. Nurses' perceptions towards the delivery and feasibility of a behaviour change intervention to enhance physical activity in patients at risk for cardiovascular disease in primary care: a qualitative study. BMC Fam Pract. 2018 Dec 12;19(1):194. doi: 10.1186/s12875-018-0888-1.
- Westland H, Bos-Touwen ID, Trappenburg JC, Schroder CD, de Wit NJ, Schuurmans MJ. Unravelling effectiveness of a nurse-led behaviour change intervention to enhance physical activity in patients at risk for cardiovascular disease in primary care: study protocol for a cluster randomised controlled trial. Trials. 2017 Feb 22;18(1):79. doi: 10.1186/s13063-017-1823-9.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL54286.041.15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Activate
-
New York UniversityCompleted
-
Anita Misra-HebertPatient-Centered Outcomes Research Institute; The Cleveland ClinicEnrolling by invitationObesity & OverweightUnited States
-
Anthony Sung, MDNot yet recruitingStem Cell Transplant PatientsUnited States
-
University of California, San FranciscoCompleted
-
Dr. Behcet Uz Children's HospitalCompletedAcute Respiratory Failure | Acute Hypoxemic Respiratory Failure | Acute Hypoxemic and Hypercapnic Respiratory FailureTurkey
-
Bruyere Research InstituteUniversity of OttawaCompletedMild Cognitive Impairment | Alzheimer's Disease | Mild to Moderate DementiaCanada
-
Wayne State UniversityUniversity of Maryland, College Park; Detroit Recovery Project INCRecruitingMajor Depressive Disorder | Substance Use DisordersUnited States
-
VA Office of Research and DevelopmentRecruitingFunctional IndependenceUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of CologneUnknownOppositional Defiant DisorderGermany